Literature DB >> 8617768

The ultrastructure of fibrinogen Caracas II molecules, fibers, and clots.

J L Woodhead1, C Nagaswami, M Matsuda, C L Arocha-Piñango, J W Weisel.   

Abstract

Fibrinogen Caracas II is an abnormal fibrinogen involving the mutation of A alpha serine 434 to N-glycosylated asparagine. Some effects of this mutation on the ultrastructure of fibrinogen Caracas II molecules, fibers, and clots were investigated by electron microscopy. Electron microscopy of rotary shadowed individual molecules indicated that most of the alphaC domains of fibrinogen Caracas II do not interact with each other or with the central domain, in contrast to control fibrinogen. Negatively contrasted Caracas II fibers were thinner and less ordered than control fibers, and many free fiber ends were observed. Scanning electron microscopy of whole clots revealed the presence of large pores bounded by local fiber networks made up of thin fibers. Permeation experiments also indicated that the average pore diameter was larger than that of control clots. The viscoelastic properties of the Caracas II clot, as measured by a torsion pendulum, were similar to those of control clots. Both the normal stiffness and increased permeability of the Caracas II clots are consistent with the observation that subjects with this dysfibrinogenemia are asymptomatic.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617768     DOI: 10.1074/jbc.271.9.4946

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.

Authors:  Jean-Philippe Collet; Jennifer L Moen; Yuri I Veklich; Oleg V Gorkun; Susan T Lord; Gilles Montalescot; John W Weisel
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

2.  Direct evidence for specific interactions of the fibrinogen alphaC-domains with the central E region and with each other.

Authors:  Rustem I Litvinov; Sergiy Yakovlev; Galina Tsurupa; Oleg V Gorkun; Leonid Medved; John W Weisel
Journal:  Biochemistry       Date:  2007-07-13       Impact factor: 3.162

3.  Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury.

Authors:  Nathan J White; Yi Wang; Xiaoyun Fu; Jessica C Cardenas; Erika J Martin; Donald F Brophy; Charles E Wade; Xu Wang; Alexander E St John; Esther B Lim; Susan A Stern; Kevin R Ward; José A López; Dominic Chung
Journal:  Free Radic Biol Med       Date:  2016-04-20       Impact factor: 7.376

4.  Thrombin flux and wall shear rate regulate fibrin fiber deposition state during polymerization under flow.

Authors:  K B Neeves; D A R Illing; S L Diamond
Journal:  Biophys J       Date:  2010-04-07       Impact factor: 4.033

Review 5.  Structure and function of human fibrinogen inferred from dysfibrinogens.

Authors:  Michio Matsuda; Teruko Sugo
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia.

Authors:  Muhua Cao; Tao Li; Zhangxiu He; Lixiu Wang; Xiaoyan Yang; Yan Kou; Lili Zou; Xue Dong; Valerie A Novakovic; Yayan Bi; Junjie Kou; Bo Yu; Shaohong Fang; Jinghua Wang; Jin Zhou; Jialan Shi
Journal:  Blood       Date:  2017-01-04       Impact factor: 22.113

7.  The presence of gamma' chain impairs fibrin polymerization.

Authors:  Kathryn C Gersh; Chandrasekaran Nagaswami; John W Weisel; Susan T Lord
Journal:  Thromb Res       Date:  2009-01-12       Impact factor: 3.944

8.  Polyphosphate enhances fibrin clot structure.

Authors:  Stephanie A Smith; James H Morrissey
Journal:  Blood       Date:  2008-06-10       Impact factor: 22.113

9.  Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.

Authors:  Marlien Pieters; Namukolo Covic; Francois H van der Westhuizen; Chandrasekaran Nagaswami; Yelena Baras; Du Toit Loots; Johann C Jerling; Dale Elgar; Kathryn S Edmondson; Danie G van Zyl; Paul Rheeder; John W Weisel
Journal:  Thromb Haemost       Date:  2008-04       Impact factor: 5.249

10.  Fibrinogen Yecheon: congenital dysfibrinogenemia with gamma methionine-310 to threonine substitution.

Authors:  Eunkyung Park; Geumbore Park; Rojin Park; Hee-Jin Kim; Sang Jae Lee; Young Joo Cha
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.